XERS logo

Xeris Biopharma Holdings (XERS) Operating profit

annual operating profit:

-$33.65M+$10.36M(+23.55%)
December 31, 2024

Summary

  • As of today (June 24, 2025), XERS annual operating income is -$33.65 million, with the most recent change of +$10.36 million (+23.55%) on December 31, 2024.
  • During the last 3 years, XERS annual operating profit has risen by +$81.51 million (+70.78%).
  • XERS annual operating profit is now -154.30% below its all-time high of -$13.23 million, reached on December 31, 2016.

Performance

XERS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

quarterly operating profit:

-$3.09M-$4.77M(-284.04%)
March 1, 2025

Summary

  • As of today (June 24, 2025), XERS quarterly operating income is -$3.09 million, with the most recent change of -$4.77 million (-284.04%) on March 1, 2025.
  • Over the past year, XERS quarterly operating profit has increased by +$11.15 million (+78.31%).
  • XERS quarterly operating profit is now -284.04% below its all-time high of $1.68 million, reached on December 31, 2024.

Performance

XERS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM operating profit:

-$22.49M+$11.15M(+33.15%)
March 1, 2025

Summary

  • As of today (June 24, 2025), XERS TTM operating income is -$22.49 million, with the most recent change of +$11.15 million (+33.15%) on March 1, 2025.
  • Over the past year, XERS TTM operating profit has increased by +$22.49 million (+50.00%).
  • XERS TTM operating profit is now -383.78% below its all-time high of -$4.65 million, reached on March 31, 2017.

Performance

XERS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

XERS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.6%+78.3%+50.0%
3 y3 years+70.8%+89.4%+82.4%
5 y5 years+72.5%+89.1%+82.0%

XERS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+70.8%-284.0%+89.4%at high+82.4%
5 y5-yearat high+72.5%-284.0%+93.6%at high+82.4%
alltimeall time-154.3%+72.5%-284.0%+93.6%-383.8%+82.4%

XERS Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$3.09M(-284.0%)
-$22.49M(-33.2%)
Dec 2024
-$33.65M(-23.5%)
$1.68M(-113.0%)
-$33.65M(-25.5%)
Sep 2024
-
-$12.89M(+57.5%)
-$45.17M(+21.5%)
Jun 2024
-
-$8.19M(-42.5%)
-$37.19M(-17.3%)
Mar 2024
-
-$14.24M(+44.8%)
-$44.98M(+2.2%)
Dec 2023
-$44.01M(-46.3%)
-$9.84M(+100.3%)
-$44.01M(-10.8%)
Sep 2023
-
-$4.91M(-69.3%)
-$49.34M(-21.9%)
Jun 2023
-
-$15.98M(+20.4%)
-$63.21M(-4.4%)
Mar 2023
-
-$13.28M(-12.5%)
-$66.14M(-19.3%)
Dec 2022
-$81.94M(-28.8%)
-$15.17M(-19.2%)
-$81.94M(-28.8%)
Sep 2022
-
-$18.78M(-0.7%)
-$115.04M(-4.6%)
Jun 2022
-
-$18.92M(-34.9%)
-$120.62M(-5.4%)
Mar 2022
-
-$29.07M(-39.8%)
-$127.49M(+10.7%)
Dec 2021
-$115.16M(+37.8%)
-$48.27M(+98.2%)
-$115.16M(+33.5%)
Sep 2021
-
-$24.36M(-5.5%)
-$86.23M(+14.0%)
Jun 2021
-
-$25.79M(+54.0%)
-$75.61M(+5.0%)
Mar 2021
-
-$16.74M(-13.5%)
-$72.03M(-13.8%)
DateAnnualQuarterlyTTM
Dec 2020
-$83.55M(-31.7%)
-$19.34M(+40.7%)
-$83.55M(-13.9%)
Sep 2020
-
-$13.74M(-38.1%)
-$97.00M(-14.4%)
Jun 2020
-
-$22.20M(-21.4%)
-$113.34M(-9.5%)
Mar 2020
-
-$28.25M(-13.9%)
-$125.20M(+2.3%)
Dec 2019
-$122.38M(+106.2%)
-$32.80M(+9.0%)
-$122.38M(+11.4%)
Sep 2019
-
-$30.08M(-11.7%)
-$109.89M(+16.0%)
Jun 2019
-
-$34.06M(+33.9%)
-$94.75M(+29.7%)
Mar 2019
-
-$25.44M(+25.2%)
-$73.05M(+23.1%)
Dec 2018
-$59.34M(+122.9%)
-$20.31M(+35.9%)
-$59.34M(+23.0%)
Sep 2018
-
-$14.94M(+20.9%)
-$48.24M(+18.0%)
Jun 2018
-
-$12.36M(+5.3%)
-$40.87M(+21.2%)
Mar 2018
-
-$11.73M(+27.4%)
-$33.71M(+26.6%)
Dec 2017
-$26.63M(+101.3%)
-$9.21M(+21.6%)
-$26.63M(+52.9%)
Sep 2017
-
-$7.57M(+45.6%)
-$17.42M(+76.9%)
Jun 2017
-
-$5.20M(+11.8%)
-$9.85M(+111.8%)
Mar 2017
-
-$4.65M
-$4.65M
Dec 2016
-$13.23M
-
-

FAQ

  • What is Xeris Biopharma Holdings annual operating income?
  • What is the all time high annual operating profit for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings annual operating profit year-on-year change?
  • What is Xeris Biopharma Holdings quarterly operating income?
  • What is the all time high quarterly operating profit for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings quarterly operating profit year-on-year change?
  • What is Xeris Biopharma Holdings TTM operating income?
  • What is the all time high TTM operating profit for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings TTM operating profit year-on-year change?

What is Xeris Biopharma Holdings annual operating income?

The current annual operating profit of XERS is -$33.65M

What is the all time high annual operating profit for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high annual operating income is -$13.23M

What is Xeris Biopharma Holdings annual operating profit year-on-year change?

Over the past year, XERS annual operating income has changed by +$10.36M (+23.55%)

What is Xeris Biopharma Holdings quarterly operating income?

The current quarterly operating profit of XERS is -$3.09M

What is the all time high quarterly operating profit for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high quarterly operating income is $1.68M

What is Xeris Biopharma Holdings quarterly operating profit year-on-year change?

Over the past year, XERS quarterly operating income has changed by +$11.15M (+78.31%)

What is Xeris Biopharma Holdings TTM operating income?

The current TTM operating profit of XERS is -$22.49M

What is the all time high TTM operating profit for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high TTM operating income is -$4.65M

What is Xeris Biopharma Holdings TTM operating profit year-on-year change?

Over the past year, XERS TTM operating income has changed by +$22.49M (+50.00%)
On this page